2291-2893 Screening compound: N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-yl]-4-(pyrrolidine-1-sulfonyl)benzamide

2291-2893 Screening compound: N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-yl]-4-(pyrrolidine-1-sulfonyl)benzamide
2291-2893 Screening compound: N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-yl]-4-(pyrrolidine-1-sulfonyl)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2291-2893
N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-yl]-4-(pyrrolidine-1-sulfonyl)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2291-2893

Molecular Formula

C19H16Cl2N4O3S2 (C19 H16 Cl2 N4 O3 S2)

Compound Name

N-[5-(2,4-dichlorophenyl)-1,3,4-thiadiazol-2-yl]-4-(pyrrolidine-1-sulfonyl)benzamide

IUPAC name

N-[5-(24-dichlorophenyl)-134-thiadiazol-2-yl]-4-(pyrrolidine-1-sulfonyl)benzamide

SMILES

O=C(c(cc1)ccc1S(N1CCCC1)(=O)=O)Nc1nnc(-c(ccc(Cl)c2)c2Cl)s1

InChI

InChI=1S/C19H16Cl2N4O3S2/c20-13-5-8-15(16(21)11-13)18-23-24-19(29-18)22-17(26)12-3-6-14(7-4-12)30(27,28)25-9-1-2-10-25/h3-8,11H,1-2,9-10H2,(H,22,24,26)

InChI Key

UQDYEQWPJZPHRX-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01538373

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

483.4

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.738

Distribution Coefficient, logD

4.610

Water Solubility, LogSw

-5.06

Polar Surface Area

78.680

Acid Dissociation Constant (pKa)

7.87

Base Dissociation Constant (pKb)

-3.52

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.10

2291-2893 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with 2291-2893 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2291-2893?
Check Price and Availability of 2291-2893, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2291-2893 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2291-2893
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2291-2893
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2291-2893 available by request